Showing results (1441-1450 of 1,529) with videos related to

Sort By:
Pageof 153
Bioorganic & Medicinal Chemistry Letters|October 24, 2006
(3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesTesfaye Biftu, Dennis Feng, Xiaoxia Qian, et al.
Blood|November 28, 2022
Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic strokeChristopher M Arends, Thomas G Liman, Paulina M Strzelecka, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2017
Concise syntheses and HCV NS5B polymerase inhibition of (2'R)-3 and (2'S)-2'-ethynyluridine-10 and related nucleosidesFrank Bennett, Alexei V Buevich, Hsueh-Cheng Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|April 6, 2021
COVID-19 vaccine impact on rates of SARS-CoV-2 cases and post vaccination strain sequences among healthcare workers at an urban academic medical center: a prospective cohort studyTara C Bouton, Sara Lodi, Jacquelyn Turcinovic, et al.
British Journal of Cancer|October 26, 2013
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patientsP Dubsky, J C Brase, R Jakesz, et al.
Breast Cancer Research and Treatment|September 7, 2017
Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trialsMarion T van Mackelenbergh, Carsten Denkert, Valentina Nekljudova, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitorsJinyou Xu, Lan Wei, Robert J Mathvink, et al.
Breast Cancer Research : BCR|December 13, 2019
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapyBruno Valentin Sinn, Karsten E Weber, Wolfgang Daniel Schmitt, et al.
Materials (Basel, Switzerland)|January 1, 2021
Novel Low-Twist Bast Fibre Yarns from Flax Tow for High-Performance Composite ApplicationsNina Graupner, Karl-Heinz Lehmann, David E Weber, et al.
Breast Cancer Research and Treatment|August 20, 2017
BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trialA G J van Rossum, P C Schouten, K E Weber, et al.
Pageof 153